Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT [NA]

View source ↗

Summary

A recruiting clinical trial evaluating Saline Enhanced Radiofrequency (SERF) Needle Ablation for refractory ventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saline Enhanced Radiofrequency (SERF) Needle Ablation

Snippet

Sponsor: Thermedical, Inc. | Conditions: Refractory Ventricular Tachycardia | NA | Status: RECRUITING